Literature DB >> 28253425

Using cancer genomics to guide clinical decisions.

Mark E Burkard1, Dustin A Deming2,3, Josh Lauring3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28253425      PMCID： PMC5789460          DOI： 10.1002/cncr.30640

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  14 in total

1.  Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.

Authors:  Bella Kaufman; Ronnie Shapira-Frommer; Rita K Schmutzler; M William Audeh; Michael Friedlander; Judith Balmaña; Gillian Mitchell; Georgeta Fried; Salomon M Stemmer; Ayala Hubert; Ora Rosengarten; Mariana Steiner; Niklas Loman; Karin Bowen; Anitra Fielding; Susan M Domchek
Journal:  J Clin Oncol       Date:  2014-11-03       Impact factor: 44.544

2.  Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.

Authors:  Jianjiong Gao; Bülent Arman Aksoy; Ugur Dogrusoz; Gideon Dresdner; Benjamin Gross; S Onur Sumer; Yichao Sun; Anders Jacobsen; Rileen Sinha; Erik Larsson; Ethan Cerami; Chris Sander; Nikolaus Schultz
Journal:  Sci Signal       Date:  2013-04-02       Impact factor: 8.192

3.  Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

Authors:  Mark G Kris; Bruce E Johnson; Lynne D Berry; David J Kwiatkowski; A John Iafrate; Ignacio I Wistuba; Marileila Varella-Garcia; Wilbur A Franklin; Samuel L Aronson; Pei-Fang Su; Yu Shyr; D Ross Camidge; Lecia V Sequist; Bonnie S Glisson; Fadlo R Khuri; Edward B Garon; William Pao; Charles Rudin; Joan Schiller; Eric B Haura; Mark Socinski; Keisuke Shirai; Heidi Chen; Giuseppe Giaccone; Marc Ladanyi; Kelly Kugler; John D Minna; Paul A Bunn
Journal:  JAMA       Date:  2014-05-21       Impact factor: 56.272

4.  Molecular analysis for therapy choice: NCI MATCH.

Authors:  Barbara A Conley; James H Doroshow
Journal:  Semin Oncol       Date:  2014-05-22       Impact factor: 4.929

Review 5.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

6.  Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative.

Authors:  Apostolia-Maria Tsimberidou; Nancy G Iskander; David S Hong; Jennifer J Wheler; Gerald S Falchook; Siqing Fu; Sarina Piha-Paul; Aung Naing; Filip Janku; Rajyalakshmi Luthra; Yang Ye; Sijin Wen; Donald Berry; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2012-09-10       Impact factor: 12.531

7.  A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation.

Authors:  Justin Lee; Jennifer Axilbund; W Brian Dalton; Daniel Laheru; Stanley Watkins; David Chu; Karen Cravero; Berry Button; Kelly Kyker-Snowman; Ian Waters; Christopher D Gocke; Josh Lauring; Ben Ho Park
Journal:  J Natl Compr Canc Netw       Date:  2016-12       Impact factor: 11.908

Review 8.  Neoantigens in cancer immunotherapy.

Authors:  Ton N Schumacher; Robert D Schreiber
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

9.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer.

Authors:  Simon A Forbes; David Beare; Prasad Gunasekaran; Kenric Leung; Nidhi Bindal; Harry Boutselakis; Minjie Ding; Sally Bamford; Charlotte Cole; Sari Ward; Chai Yin Kok; Mingming Jia; Tisham De; Jon W Teague; Michael R Stratton; Ultan McDermott; Peter J Campbell
Journal:  Nucleic Acids Res       Date:  2014-10-29       Impact factor: 16.971

10.  Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.

Authors:  Milan Radovich; Patrick J Kiel; Stacy M Nance; Erin E Niland; Megan E Parsley; Meagan E Ferguson; Guanglong Jiang; Natraj R Ammakkanavar; Lawrence H Einhorn; Liang Cheng; Mehdi Nassiri; Darrell D Davidson; Daniel A Rushing; Patrick J Loehrer; Roberto Pili; Nasser Hanna; J Thomas Callaghan; Todd C Skaar; Paul R Helft; Safi Shahda; Bert H O'Neil; Bryan P Schneider
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.